Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000034220Phase 4Not yet recruiting
Phase 4, open-label trial of propofol and remifentanil in inguinal hernia (3 arms), sponsored by Zhongshan Boai Hospital. Primary endpoint: Intubation response. Planned start Jun 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000034220.